XML 132 R117.htm IDEA: XBRL DOCUMENT v3.25.4
SCHEDULE II CONDENSED FINANCIAL INFORMATION OF REGISTRANT PARENT COMPANY ONLY (STATEMENTS OF CASH FLOWS) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities      
Net income $ 662.5 $ 426.0 $ 35.3
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Deferred income tax benefit 14.1 (18.8) (24.6)
Change in expenses and taxes payable 58.9 (8.7) 48.0
Other, net 21.2 62.8 1.3
Net cash provided by operating activities 1,178.1 806.4 361.7
Cash flows from investing activities      
Proceeds from disposals and maturities of fixed maturities 1,452.9 1,844.1 168.8
Proceeds from disposals of equity securities and other investments 101.4 115.5 141.1
Purchase of fixed maturities (3,307.9) (3,240.7) (1,059.8)
Purchase of equity securities and other investments (78.4) (72.0) (70.8)
Net cash used in investing activities (666.2) (540.9) (228.5)
Cash flows from financing activities      
Proceeds from exercise of employee stock options 15.4 16.7 6.5
Proceeds from issuance of debt, net 495.0 0.0 0.0
Dividends paid to shareholders (130.6) (124.1) (117.2)
Repayment of debt (61.8) 0.0 0.0
Repurchases of common stock (129.2) (26.7) 0.0
Net cash provided by (used in) financing activities 175.2 (145.5) (122.1)
Cash and cash equivalents, beginning of year 435.5 316.1 305.0
Cash and cash equivalents, end of year 1,122.7 435.5 316.1
The Hanover Insurance Group [Member]      
Cash flows from operating activities      
Net income 662.5 426.0 35.3
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Net realized investment losses 0.2 4.6 1.1
Equity in net income of subsidiaries (692.0) (457.9) (62.2)
Dividends received from subsidiaries. net of capital contributed 1.3 75.5 0.7
Deferred income tax benefit (1.3) (1.9) (0.4)
Change in expenses and taxes payable 11.6 (1.9) (5.6)
Change in net receivable from subsidiaries 26.5 23.2 24.1
Other, net 2.4 1.0 1.4
Net cash provided by operating activities 11.2 68.6 (5.6)
Cash flows from investing activities      
Proceeds from disposals and maturities of fixed maturities 237.5 187.8 111.4
Proceeds from disposals of equity securities 0.2 0.2  
Purchase of fixed maturities (46.1) (103.4)  
Net cash used in investing activities 191.6 84.6 111.4
Cash flows from financing activities      
Proceeds from exercise of employee stock options 15.4 16.7 6.5
Proceeds from issuance of debt, net 495.0    
Dividends paid to shareholders (130.6) (124.1) (117.2)
Repayment of debt (61.8)    
Repurchases of common stock (129.2) (26.7)  
Net cash provided by (used in) financing activities 188.8 (134.1) (110.7)
Net change in cash and cash equivalents 391.6 19.1 (4.9)
Cash and cash equivalents, beginning of year 57.4 38.3 43.2
Cash and cash equivalents, end of year $ 449.0 $ 57.4 $ 38.3